Koyfin Home > Directory > Health Care > Antares Pharma > Capital Expenditures

Antares Pharma Capital Expenditures Chart (ATRS)

Antares Pharma annual/quarterly Capital Expenditures from 2000 to 2018.
  • Antares Pharma Capital Expenditures for the quarter ending September 09, 2018 was $0m a -51.66% increase of 0m year over year
  • Antares Pharma Capital Expenditures for the last 12 months ending September 09, 2018 was $-1m a -43.37% increase of 0m year over year
  • Antares Pharma Annual Capital Expenditures for 2017 was $-1m a -318.17% increase of 4m from 2016
  • Antares Pharma Annual Capital Expenditures for 2016 was $-5m a -15.64% increase of 1m from 2015
  • Antares Pharma Annual Capital Expenditures for 2015 was $-6m a 17.36% decrease of -1m from 2014
Other Cash Flow Metrics:
  • Antares Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $0m a -9,658.63% increase of 8m year over year
  • Antares Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $0m a -10,730.73% increase of 6m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Capital Expenditures Data

09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m
09/2017$0m
06/2017$0m
03/2017$0m
12/2016$-1m
09/2016$-2m
06/2016$-1m

Annual ATRS Capital Expenditures Data

2017$-1m
2016$-5m
2015$-6m
2014$-5m
2013$-3m
2012$-3m
2011$0m
2010$0m
2009$0m
2008$-1m